Despite roadblocks, demand for treatments persists: IQVIA
(marchmeena29/iStock via Getty Images Plus) Look for advances in decentralized trials, data collection, remote monitoring and other areas, says a leader from the research tech solutions firm. Outsourcing-Pharma (OSP) chatted with Costa Panagos (CP) president of R&D operations with IQVIA, about the developments with the most significant impact on the clinical research field in 2020, and the trends most likely to drive industry evolution in the coming year. OSP: What do you think were the biggest stories in clinical research and drug development this year? CP: In ...
Source: outsourcing-pharma.com